Unlocking the Commercial Potential of SynBio
The European Pharmaceutical Review website noted that the volume of ongoing work to link breakthroughs in basic synthetic biology with promising applications underscores its considerable potential to generate both transformative tools and products. Open innovation will be increasingly important in turning these amazing advances into positive patient
Comments Off on Unlocking the Commercial Potential of SynBio • Read this story »
More Articles
Open Innovation Case Studies
The IMI website announced a symposium at the 6th Pharmaceutical Science World Congress: “Putting open innovation into practice–case studies from Europe”. The congress will take place in Stockholm, Sweden, on on May 21 to 24, 2017. IMI is working to facilitate open innovation among the
Comments Off on Open Innovation Case Studies • Read this story »
Opening Up Innovation
The pmlive website noted that the [pharma] industry is increasingly open to academic collaborations and alongside this a more radical step can be seen in pharma’s willingness to move beyond ‘not invented here’ and take part in ‘open innovation’ initiatives. The trend is
Comments Off on Opening Up Innovation • Read this story »
Pathways to Efficient Drug Development
The Netgadget website reported that collaboration and open innovation will play increasingly important roles in the future by enabling research that would not be possible for companies to undertake individually. Many examples exist, driven in large part by the FDAs Critical Path Initiative and the European
Comments Off on Pathways to Efficient Drug Development • Read this story »
Open innovation and Bioscience
A blog on the BBSRC website noted two key concepts that are essential to developing a true open innovation environment. The first is proactive management of intellectual property (IP). Many people confuse open access with open innovation – open access is one model of open innovation where IP is
Comments Off on Open innovation and Bioscience • Read this story »
Opening Industry-Academic Partnerships
Science magazine posted an article by Chris Tachibana which noted that research and development today is about networking, sharing, and partnering. Collaborations between industry and academia are promoted by open innovation programs, which have become a near-universal model for R&D. Pharmaceutical
Comments Off on Opening Industry-Academic Partnerships • Read this story »
Open Innovation in Drug Discovery
The Wiley Online Library site posted an article from the journal Molecular Informatics which discusses some of the strengths and limitations of open innovation in drug discovery. The ever-growing availability of large-scale open data and its maturation is having a significant impact on industrial drug-discovery,
Open Innovation Partnerships Foster Global Health Care
The Guardian newspaper posted an article which says that finding an elusive disease solution independently could mean individual glory, but also long-term research and development commitments and higher financial risk. Open innovation partnerships could significantly reduce trial and error, and lead
Sharing Open Innovation Risks and Rewards
The gantdaily website reports that a growing trend in collaborative health research is creating potentially life-saving global partnerships between pharmaceutical companies, academic researchers, disease advocates, and even the general public. The challenge is to create projects that are simple
Seven Ways to Make Open Innovation Work in Europe
The Science|Business website outlined a report describing how governments can can play a key role in triggering new models of collaboration. Government can be a catalyst – that’s one of many lessons that are starting to emerge around the world as open innovation is practiced. The report outlined